Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Cash from Financing Activities (2016 - 2025)

Bio Key International's Cash from Financing Activities history spans 14 years, with the latest figure at $962508.0 for Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 44.94% year-over-year to $962508.0; the TTM value through Sep 2025 reached $3.6 million, down 30.59%, while the annual FY2024 figure was $2.8 million, 97.21% up from the prior year.
  • Cash from Financing Activities for Q3 2025 was $962508.0 at Bio Key International, up from -$35722.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $3.5 million in Q1 2025 and bottomed at -$833560.0 in Q4 2024.
  • The 5-year median for Cash from Financing Activities is $17055.5 (2021), against an average of $650059.3.
  • The largest YoY upside for Cash from Financing Activities was 24623.56% in 2024 against a maximum downside of 153.47% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $36630.0 in 2021, then surged by 4989.04% to $1.9 million in 2022, then dropped by 16.38% to $1.6 million in 2023, then tumbled by 153.47% to -$833560.0 in 2024, then skyrocketed by 215.47% to $962508.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Cash from Financing Activities are $962508.0 (Q3 2025), -$35722.0 (Q2 2025), and $3.5 million (Q1 2025).